retatroid

The Eli Lilly logo is seen at the company’s office on November 21, 2025 in San Diego, California, United States. Mike Black | Reuters Eli Lilly It said Thursday that its next-generation obesity drug retatrotide has cleared its first late-stage trials in type 2 diabetes patients, helping them manage blood sugar levels and lose weight. … Read more